Prion and CJD Instrument Decontamination Protocols

Every other pathogen your sterile services department handles has a membrane, a nucleic acid, or a protein coat that steam at 134 °C will wreck. A prion has none of those. It is a misfolded form of a protein the patient’s own body already makes, it carries no genome, and the thing that makes it infectious — the folded shape — is the most thermally stable structure in the room.

That single fact rewrites the entire reprocessing chain. Cycles that are validated, documented and genuinely effective against every organism on your routine test list are not adequate here, and a department that treats a suspected Creutzfeldt-Jakob disease case as “the usual cycle, run twice” has not understood the problem.

This guide sets out how prion decontamination differs from routine reprocessing, what the recognised protocols actually specify, and — the part that gets skipped — what it means for instrument procurement.

Why the ordinary rules do not apply

Three properties of the abnormal prion protein drive everything that follows.

It survives standard steam. Routine porous-load cycles at 134 °C for 3 to 3.5 minutes leave meaningful infectivity behind. The recognised prion cycle is 134 °C held for 18 minutes — roughly five times the routine hold.

It binds tenaciously to stainless steel. This is the property that matters most and is least appreciated. Published work on steel monofilaments has shown that prion protein adsorbs to steel surfaces and remains infectious after washing that would remove any ordinary soil. A visually clean instrument is not a decontaminated one. The steel finish itself becomes part of the risk.

Drying makes it worse. Once blood and tissue dry onto an instrument, the bound protein becomes markedly harder to detach. The window between the operating table and the start of reprocessing is not a housekeeping detail here; it is a control measure.

Put together, those three properties mean the goal shifts from kill to remove and destroy. Cleaning is not the preliminary to sterilization in a prion protocol — it carries most of the load.

The recognised protocols

The combined chemical-plus-heat protocols recommended by WHO and by CDC remain the reference points. In summary form:

Two honest caveats belong alongside that table. First, published inactivation studies using human-derived prion strains have reported reductions of under 3 log₁₀ for 1 M sodium hydroxide for an hour and for 134 °C for 18 minutes taken alone — which is why the protocols are combined, and why single-use and quarantine remain on the list rather than being treated as a last resort for the timid.

Second, the chemical routes carry real handling risk. Incidents involving spills, severe corrosion and at least one reported autoclave explosion are documented in the literature around 1 N sodium hydroxide autoclaving. Any department adopting that route needs the engineering controls and the training to match, not just the SOP.

Risk stratification is the practical starting point

Almost nobody runs a full prion protocol on every set, and nobody should. The workable approach is to stratify by tissue infectivity and patient status.

High-infectivity tissues: brain, spinal cord, dura mater, pituitary, and the posterior eye. Neurosurgical, spinal, ophthalmic posterior-segment and certain ENT skull-base instruments used on a known or suspected case fall into the strictest category.

Lower-infectivity tissues: most other tissues in most other procedures. Routine reprocessing applies.

Patient categories: confirmed CJD or variant CJD; clinically suspected cases pending investigation; and patients with identified risk factors such as a family history of prion disease, receipt of human-derived pituitary hormone, or a dura mater graft.

The decision that actually has to be made in the moment is usually not “which chemical” but “quarantine or destroy”. Instruments used on a suspected case whose diagnosis is not yet confirmed are typically quarantined intact — not reprocessed at all — until the diagnosis is settled. Reprocessing them normally in the interim is the single most common way a department loses the ability to make a good decision later.

What quarantine actually involves

Quarantine sounds administratively simple and rarely is. It means:

• The full set, not selected items, kept together and identified to the case.
• Kept moist or otherwise prevented from drying, because a dried set is a set you can no longer clean effectively if you later decide to try.
• Stored securely, labelled unambiguously, with a documented owner and a review date tied to the diagnostic pathway.
• A written disposal route if the diagnosis is confirmed — normally incineration.
• A replacement set available, because the theatre list does not pause for a diagnostic workup.

That last point is the procurement consequence, and it is the one that ends up on a purchasing desk. A department with exactly one neuro set has no quarantine option; it has a choice between a risky reprocess and a cancelled list.

Cleaning quality carries the protocol

Because destruction is incomplete, the removal step does disproportionate work. Everything that makes routine cleaning good makes prion decontamination possible.

Keep instruments moist from the point of use. Get them to the washer-disinfector quickly. Use an alkaline or a prion-active enzymatic chemistry — work on protease-based enzymatic detergent treatment has shown meaningful reduction of protease-resistant prion protein bound to surgical-steel surfaces, which is the whole point of choosing the chemistry deliberately rather than by price.

Validate the machine, not just the cycle number: our explainer on the A₀ value in washer-disinfectors covers how thermal disinfection is actually quantified, and the CSSD workflow guide sets out the clean/dirty separation that makes any of this auditable. Water chemistry matters more than most departments assume — final-rinse quality drives both residue and staining.

Then verify the load with the indicators you would use for any critical cycle; our note on chemical and biological indicators applies unchanged, with one caveat worth stating plainly: no routine indicator demonstrates prion inactivation. A passed biological indicator tells you the cycle reached its physical parameters. It does not tell you the prion load is gone.

Instrument design and material consequences

This is where prion protocols collide with what is on your shelf.

Complex geometry becomes a liability. Box joints, cannulated shafts, blind holes, ratchets and long narrow lumens are exactly the features that hold protein and resist both mechanical action and chemical contact. For high-risk neurological work, simpler is genuinely safer.

Surface finish matters. A smooth, fully passivated finish presents less area for protein to bind and releases soil more readily than a scratched or pitted one. Instruments that have been through years of abrasive handling are worse candidates for a prion protocol than new ones, which is an argument for retiring tired sets rather than nursing them.

Not every steel survives the chemistry. 20,000 ppm hypochlorite will attack martensitic stainless steels such as AISI 410 and 420 — the grades used for cutting instruments — causing pitting and loss of edge. Austenitic grades like 316L tolerate it better but are not immune. In practice, a set that has been through a full hypochlorite protocol frequently comes out unfit for further clinical use, which collapses the distinction between “decontaminate” and “destroy”.

Single-use has a real role. For defined high-risk procedures — tonsillectomy in some national guidance, certain neurosurgical and ophthalmic steps — purpose-made single-use instruments remove the reprocessing question entirely. The trade-off is cost and, sometimes, a genuine reduction in instrument quality that surgeons will notice and object to. That objection deserves to be taken seriously rather than overruled by policy.

Where low-temperature processing is being considered as an alternative, understand what it is and is not: our comparison of EtO and hydrogen peroxide sterilization explains those modalities, neither of which is a recognised prion protocol.

The awkward cases: dental files, flexible devices and shared trays

Written protocols tend to assume a rigid stainless set that can be immersed, autoclaved or incinerated. Three categories sit badly in that assumption, and they are where departments get caught.

Endodontic files and reamers. Nickel-titanium root canal instruments are fine, complex, expensive, and contact tissue that is not high-infectivity in most classifications — yet they are among the hardest items to clean, with flutes and spiral geometry that trap debris. They also do not tolerate the aggressive chemical routes; hypochlorite and strong alkali degrade NiTi surface properties and can alter the fatigue behaviour of an instrument whose whole value is controlled flexibility. Research into gentler chaotropic agents such as guanidine thiocyanate for NiTi files exists precisely because the standard options are unusable here. In most dental settings the practical answer has moved toward single-use files, which resolves the reprocessing question and the file-fatigue question at the same time.

Flexible endoscopes and powered devices. Anything that cannot take 134 °C is outside every recognised prion protocol by definition. Long narrow channels are also the worst possible geometry for protein removal. Where a flexible device has been used on high-infectivity tissue in a known or suspected case, the realistic options are quarantine or disposal — there is no low-temperature chemistry that substitutes. Powered drills and saws used in craniotomy raise the same issue in a different form: the handpiece may be autoclavable, but the internal mechanism is not cleanable to the standard the protocol assumes.

Shared and pooled trays. Most departments do not keep a dedicated neuro set per surgeon; they pool. The moment an instrument from a quarantined case has been returned to a shared pool, the boundary of the incident stops being one set and becomes everything that pool has touched since. This is an organisational failure, not a technical one, and it is prevented by a single decision made in advance: which sets are ring-fenced for high-infectivity procedures, and who has the authority to stop one being broken up for spares.

A related trap is the loan set. Instruments arriving from a supplier or another hospital for a specific case carry no reprocessing history you can inspect, and go back into circulation elsewhere afterwards. If a loan set is used on a high-risk procedure, the quarantine obligation follows the set out of your building — which means the paperwork has to be in place before the case, not after it.

Documentation and traceability

Traceability stops being a compliance formality here and becomes the mechanism by which a look-back is possible at all. If a patient is diagnosed with CJD months after surgery, the question is which sets were used and where they have been since.

That requires instrument-level or at minimum set-level tracking linked to the patient record, retained for a long horizon — prion disease incubation is measured in years. Laser-marked identifiers, set inventories that are actually maintained, and reprocessing records that survive a system migration are what make the retrospective answerable.

Manufacturers have a role in this too. Instrument marking, material declarations and reprocessing instructions that state validated parameters honestly — rather than a generic “autoclavable” — are what let a department decide whether a given set can take a prion cycle at all. Fizza Surgical’s instruments are manufactured under ISO 13485 and CE marking; our certifications page sets out the current documentation.

A workable departmental position

Most hospitals that handle this well converge on something like the following, adapted to their national guidance:

• Screen for prion risk factors pre-operatively, as part of the standard surgical checklist rather than as a special-case memo.
• Maintain a defined list of high-infectivity procedures and the sets used for them.
• Hold a documented quarantine pathway with physical space, labelling and a named owner — decided before it is needed.
• Use single-use items for the specific high-risk steps where national guidance calls for it.
• Keep cleaning quality high across the board, since the routine chain is what a prion protocol builds on.
• Maintain traceability with a retention period measured in years, not audit cycles.

The uncomfortable truth underneath all of it: there is no routine cycle that makes a prion-contaminated instrument demonstrably safe, and any protocol that claims otherwise is overstating its evidence. Effective prion decontamination is built on avoidance, removal and destruction, in that order — sterilization is the last and weakest of the three.